[ Price : $8.95]
FDA grants Sage Therapeutics an orphan drug designation for SAGE-718 and its use in treating Huntingtons disease.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Fresenius Kabis Omegaven (f...[ Price : $8.95]
Three trade groups raise concerns and make suggestions for the FDA Information Technology Strategy.[ Price : $8.95]
The Advanced Medical Technology Association urges FDA to proceed with stakeholder recommendations to develop a central patient-rep...[ Price : $8.95]
FDA issues a warning on the use of 26 over-the-counter eye drop products due to the potential risk of eye infections that could re...[ Price : $8.95]
Sarepta Therapeutics says it will file a supplemental BLA for Elevidys (delandistrogene moxeparvovec-rokl) to expand the therapys ...[ Price : $8.95]
GSK says a Phase 3 trial evaluating its Jemperli (dostarlimab) in adult patients with primary advanced or recurrent endometrial ca...[ Price : $8.95]
Novartis says it will seek FDA accelerated approval for atrasentan and its use in treating patients with IgA nephropathy.